Stock Groups

Bristol Myers to buy Turning Point for $4.1 billion -Breaking

[ad_1]

© Reuters. FILE PHOTO: A girl holds take a look at tube in entrance of displayed Bristol Myers Squibb brand on this illustration taken, Might 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photograph/File Photograph

(Corrects so as to add dropped phrase in headline)

(Reuters) – Bristol Myers (NYSE:) Squibb stated on Friday it will purchase Turning Level Therapeutics (NASDAQ:) Inc for $4.1 billion in money to realize entry to its experimental most cancers drug.

(The story corrects so as to add dropped phrase in headline.)

[ad_2]